Feverfew
Specifically for Migraine
0 up • 0 down
Why it works for Migraine:
Parthenolide and related sesquiterpene lactones — the most studied active constituents — appear to reduce inflammation and inhibit mediators involved in migraine pathways (for example: inhibit platelet aggregation and prostaglandin synthesis, modulate serotonin release, and inhibit NF-κB signaling). These actions could reduce neurogenic inflammation and the vascular/neuronal events that trigger migraines. MDPI
Modulation of sensory neurons / ion channels and neurotransmitter release — lab studies (cell and animal work) suggest feverfew components reduce excitability of trigeminal sensory neurons and blunt release of substances (like serotonin, substance P, CGRP in some models) that contribute to migraine pain. MDPI
Anti-inflammatory and antioxidant effects — multiple plant compounds in feverfew show anti-inflammatory/antioxidant effects that plausibly reduce migraine susceptibility. MDPI
How to use for Migraine:
Common whole-leaf / powdered doses used in trials: 50–150 mg/day of dried feverfew leaf (often split doses or once daily). Many older positive trials used freeze-dried whole-leaf preparations (e.g., 50 mg twice daily or 125 mg/day formulations). Cambridge University Press & Assessment
Standardization to parthenolide: trials and experts frequently emphasize standardizing to ~0.2%–0.4% parthenolide (the active marker). Look for products that list parthenolide content. ResearchGate
CO₂ extract (MIG-99) trials: some modern trials used a concentrated supercritical CO₂ extract (MIG-99) at small milligram doses given three times daily (example dose ranges reported: ~2–19 mg three times daily, depending on the study arm). These extracts are not the same as whole-leaf powders, which complicates comparisons. SAGE Journals
Duration: trials typically treated for 2–4 months (8–16 weeks) before judging effect. Most herbal prophylaxis studies advise giving the product daily for at least 2–3 months to assess benefit. Cochrane
How people take it in practice: typical consumer guidelines (and many product labels) recommend taking the standardized capsule daily, often once daily or divided doses, and continuing for several months. Always follow the product label and your clinician’s advice. Holland & Barrett
Scientific Evidence for Migraine:
Lancet randomized double-blind crossover trial (Murphy et al., 1988) — early influential RCT that suggested benefit of dried feverfew leaves versus placebo. The Lancet
BMJ / other small RCTs (1980s–1990s) — several small randomized trials (some positive, some negative) using freeze-dried leaf preparations; sample sizes were small and methods variable. Example: a small double-blind trial with fresh leaves vs placebo showed mixed results. BMJ
Dose-response multicenter randomized trial of MIG-99 (2002) — a modern double-blind multicentre randomized placebo-controlled trial that tested a standardized CO₂ extract (MIG-99) at several doses; that trial did not show a clear benefit in all endpoints, illustrating how preparation matters. SAGE Journals
Cochrane Review: “Feverfew for preventing migraine” — systematic review of randomized double-blind trials (update page summarizing evidence). The Cochrane assessments point out heterogeneity of trials and conclude evidence is inconclusive; some trials show small benefits, but quality and consistency are issues. Cochrane
Systematic reviews / updates (e.g., Cambridge review / other meta-analyses) — multiple systematic reviews (1990s–2000s and newer meta-analyses) reach similar conclusions: some positive trials exist, but overall the evidence is inconsistent and larger well-standardized trials are still needed. Cambridge University Press & Assessment
Recent mechanistic review (MDPI review on feverfew phytochemistry & mechanisms) — explains the molecular mechanisms (parthenolide, anti-inflammatory pathways) supporting a rationale for use. This helps explain why different extracts (whole-leaf vs CO₂) may produce different clinical outcomes. MDPI
Specific Warnings for Migraine:
Pregnancy & breastfeeding: Avoid. Feverfew may stimulate uterine contractions and is not recommended during pregnancy; safety in breastfeeding is not established. RxList
Bleeding / surgery risk: feverfew may have antiplatelet effects and could increase bleeding risk or interact with anticoagulants/antiplatelet drugs (warfarin, aspirin, clopidogrel). Stop before surgery and check with your clinician if you take blood thinners. Drugs.com
Allergy risk: people allergic to Asteraceae (ragweed, chamomile, chrysanthemum, marigold) may react to feverfew. RxList
Oral mucosal reactions: chewing fresh feverfew leaves can cause mouth ulcers, irritation and loss of taste. Capsules are less likely to do this. MedicineNet
Gastrointestinal / common side effects: nausea, abdominal discomfort, bloating, diarrhea, and indigestion have been reported. MedicineNet
Withdrawal / rebound: some reports indicate stopping long-term feverfew abruptly may cause rebound headaches or anxiety in some users — gradual tapering and consulting a clinician is sensible. Drugs.com
Interactions with other drugs/supplements: possible interactions with antiplatelet/anticoagulant drugs, and theoretically with drugs metabolized by certain liver enzymes — always check with a pharmacist/doctor. Drugs.com
General Information (All Ailments)
What It Is
Feverfew (Tanacetum parthenium) is a perennial herb belonging to the daisy family (Asteraceae). It has small white and yellow flowers resembling miniature daisies and has been used in traditional medicine for centuries. The plant is native to southeastern Europe but is now grown worldwide for its medicinal properties. The active compounds in feverfew—especially parthenolide, along with other sesquiterpene lactones, flavonoids, and volatile oils—are believed to be responsible for its therapeutic effects.
Traditionally, feverfew has been used for conditions like headaches, inflammation, menstrual discomfort, and arthritis. It’s available in several forms including dried leaves, capsules, tablets, and liquid extracts.
How It Works
The main active component, parthenolide, plays a key role in feverfew’s pharmacological action. It exerts anti-inflammatory and vasomodulatory effects by inhibiting certain biochemical pathways in the body:
- Anti-inflammatory action: Feverfew inhibits the release of inflammatory substances such as prostaglandins and cytokines by blocking the enzyme cyclooxygenase (COX) and limiting the activity of nuclear factor kappa B (NF-κB). This helps reduce inflammation at the cellular level.
- Serotonin regulation: It is believed to modulate serotonin (5-HT) activity in blood vessels and nerve cells. Since serotonin affects blood vessel tone and pain transmission, this may help prevent migraine onset.
- Platelet function: Feverfew may reduce the release of serotonin from platelets and inhibit their aggregation, potentially reducing vascular spasms that can trigger migraines.
- Muscle relaxation: It also has a mild relaxant effect on smooth muscles in the blood vessels, further aiding in migraine prevention.
Together, these effects contribute to feverfew’s reputation as a natural migraine prophylactic and an anti-inflammatory herb.
Why It’s Important
Feverfew is valued for its potential role in preventing migraines and reducing inflammation without the harsh side effects often associated with pharmaceutical drugs. Some key reasons for its importance include:
- Migraine management: Clinical studies suggest that regular use of feverfew may reduce the frequency, intensity, and duration of migraine attacks. It’s especially popular among individuals seeking natural alternatives to prescription migraine medications.
- Anti-inflammatory potential: By moderating inflammatory processes, feverfew may offer support in conditions like arthritis or other chronic inflammatory disorders.
- Traditional healing legacy: Its long history of use in European herbal medicine reflects its enduring role in holistic and preventive health practices.
- Natural therapy trend: With growing interest in plant-based and integrative therapies, feverfew stands out as an herb backed by both tradition and emerging scientific evidence.
Considerations
While feverfew is generally considered safe for most adults, there are important considerations and potential side effects to be aware of:
- Side effects: Some users may experience mouth ulcers, nausea, bloating, or digestive upset, especially when chewing the raw leaves.
- Allergies: Individuals allergic to plants in the Asteraceae family (such as daisies, chrysanthemums, or ragweed) should avoid feverfew.
- Pregnancy and breastfeeding: It is not recommended during pregnancy as it may trigger uterine contractions. Its safety in breastfeeding is also uncertain.
- Interactions: Feverfew may interact with anticoagulant or antiplatelet medications (like warfarin or aspirin), increasing the risk of bleeding. It may also interfere with migraine drugs that affect serotonin.
- Withdrawal symptoms: Abruptly stopping long-term use can occasionally lead to rebound headaches or muscle stiffness, known as "feverfew post-migraine syndrome."
- Consistency of use: Feverfew appears to be more effective when taken regularly over time rather than as an acute migraine remedy.
Helps with these conditions
Feverfew is most effective for general wellness support with emerging research . The effectiveness varies by condition based on clinical evidence and user experiences.
Detailed Information by Condition
Migraine
Parthenolide and related sesquiterpene lactones — the most studied active constituents — appear to reduce inflammation and inhibit mediators involved...
Community Discussion
Share results, tips, and questions about Feverfew.
Loading discussion...
No comments yet. Be the first to start the conversation!
Discussion for Migraine
Talk specifically about using Feverfew for Migraine.
Loading discussion...
No comments yet. Be the first to start the conversation!
Remedy Statistics
Helps With These Conditions
Recommended Products
No recommended products added yet.